Rain was founded with a focus on developing therapies that effectively target genetically-driven cancers to help patients live life to the fullest. Leveraging both an acquisition-based business model and internal research, we aim to become a leading precision oncology company that develops and commercializes small molecule therapies.
Our uncompromised dream is to mobilize the best precision oncology therapies for patients suffering from cancer. We are rooted in this purpose – extending the quality and length of life for cancer patients where we may be their best hope.
The Rain Team Is:
We are dedicated to helping each employee take charge to lead, and to grow professionally and personally.
We are a diverse and inclusive team. Among our 25 plus employees, 50% are women. We speak over 20 languages and hail from many countries around the world.
Rain is primarily remote during COVID-19, except for our lab. We are looking forward to – flexibly – getting back into the office located in Newark, CA.
Once it is safe, we cannot wait to get back to hosting our regular in-person team activities and events.